The following is a listing of myeloma treatments associated with this tag.
View all treatments in development for myeloma patients around the US.
RO6870810
RO6870810 is a BET inhibitor that is openly enrolling in a dose expansion clinical trial around the US.
SparkCures Verified Accurate, up-to-date information. Learn more
The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.
RO6870810
RO6870810 is a BET inhibitor that is openly enrolling in a dose expansion clinical trial around the US.
SparkCures Verified Accurate, up-to-date information. Learn more
The following is a listing of myeloma clinical trials associated with this tag.
View all active clinical trials around the US.
A Master Protocol for Biomarker-Based Treatment of AML (The Beat AML Trial)
THE BEAT AML TRIALThe following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.